Advanced Cardiac Life Support Update: Uses of Drugs

Abstract

Get full access to this article

View all access options for this article.

References

Barnes

, Durbin

Jr . ACLS skills for the respiratory therapist: time for a mandate (editorial). Respir Care 1992;37(6):516–519.

Bearden

. ACLS-one depart-ment's experience (letter). Respir Care 1992;37(8):945.

Gallo

. More on ACLS training (letter). Respir Care 1992;37(8):945–946.

Henson

Dinosaurs, RCPs, and ACLS (letter). Respir Care 1992;37(8):946–947.

Burns

Emergency care and ACLS (letter). Respir Care 1992;37(8):947–948, 1211.

Shaffer

In support of ACLS cer-tification (letter). Respir Care 1992;37(12):1446–1447.

Kacmarek

. The role of the res-piratory therapist in emergency care. Respir Care 1992;37(6):523–532.

Emergency Cardiac Care Commit-tee and Subcommittees, American Heart Association. Guidelines for cardiopulmonary resuscitation and emergency cardiac care. JAMA 1992;268:2171–2295.

Emerman

, Pinchak

, Han-cock

, Hagen

. The effect of bo-lus injection on circulation times during cardiac arrest. Am J Emerg Med 1990;8:190–193.

10.

Aitkenhead

. Drug administra-tion during CPR: what route? Re-suscitation 1991;22:191–195.

11.

MacMahon

, Collins

, Peto

, Koster

, Yusuf

Effects of pro-phylactic lidocaine in suspected acute myocardial infarction: an over-view of results from the random-ized, controlled trials. JAMA 1988;260:1910–1916.

12.

Olson

, Thompson

, Darin

, Milbrath

. A randomized comparison study of bretylium tos-ylate and lidocaine in resuscitation of patients from out-of-hospital ven-tricular fibrillation in a paramedic system. Ann Emerg Med 1984;13(9, Part 2):807–810.

13.

Woods

, Fletcher

, Roffe

, Haider

Intravenous magnesium sulphate in suspected acute myo-cardial infarction: results of the sec-ond Leicester Intravenous Magnes-ium Intervention Trial (LIMIT-2). Lancet 1992;339:1553–1558.

14.

Scheinman

, Thorburn

, Ab-bott

. Use of atropine in patients with acute myocardial infarction and sinus bradycardia. Circulation 1975;52:627–633.

15.

Stueven

, Tonsfeldt

, Thom-pson

, Whitcomb

, Kastenson

, Aprahamian

Atropine in asys-tole: human studies. Ann Emerg Med 1984;13(9, Part 2):815–817.

16.

Rankin

, Rae

, Cobbe

. Misuse of intravenous verapamil in patients with ventricular tachycar-dia. Lancet 1987;2:472–474.

17.

DiMarco

, Sellers

, Berne

, West

, Belardinelli

Adeno-sine: electrophysiologic effects and therapeutic use for terminating par-oxysmal supraventricular tachycar-dia. Circulation 1983;68:1254–1263.

18.

Rankin

, McGovern

. Aden-osine or verapamil for the acute treatment of supraventricular tachy-cardia? (editorial). Ann Intern Med 1991;114:513–515.

19.

McCabe

, Adhar

, Menegazzi

, Paris

. Intravenous adenosine in the prehospital treatment of par-oxysmal supraventricular tachycar-dia. Ann Emerg Med 1992;21:358–361.

20.

Parker

, McCollam

. Aden-osine in the episodic treatment of paroxysmal supraventricular tachy-cardia. Clin Pharm 1990;9:261–271.

21.

Lindner

, Ahnefeld

, Bowd-ler

. Comparison of ephinephrine and dopamine during cardiopul-monary resuscitation. Intensive Care Med 1989;15:432–438.

22.

Klein

, Siskind

, Frishman

, Sonnenblick

, LeJemtel

. Hemodynamic comparison of intravenous amrinone and dobuta-mine in patients with chronic con-gestive heart failure. Am J Cardiol 1981;48:170–175.

23.

Goldstein

, Passamani

, Rob-erts

A comparison of digoxin and dobutamine in patients with acute infarction and cardiac failure. N Engl J Med 1980;303:846–850.

24.

Ellenbogen

. Role of calcium an-tagonists for heart rate control in atrial fibrillation. Am J Cardiol 1992;69:36B–40B.

25.

Jaffe

, Roberts

The use of in-travenous nitroglycerin in cardio-vascular disease. Pharmacotherapy 1982;2:273–280.

26.

Zelis

, Mansour

, Capone

, Mason

. The cardiovascular ef-fects of morphine: the peripheral ca-pacitance and resistance vessels in human subjects. J Clin Invest 1974;54:1247–1258.

27.

Bishop

, Weisfeldt

. Sodium bicarbonate administration during cardiac arrest: effect on arterial pH, PCO2, and osmolality. JAMA 1976;235:506–509.

28.

Telivuo

, Maamies

, Siltanen

, Tala

Comparison of alkalizing agents in resuscitation of the heart after ventricular fibrillation. Ann Chir Gynaecol Fenn 1968;57:221–224.

29.

Mattar

, Weil

, Shubin

, Stein

Cardiac arrest in the crit-ically ill, II: hyperosmolal states fol-lowing cardiac arrest. Am J Med 1974;56:162–168.

30.

Lawson

, Butler

III , Ray

. Alkalosis and cardiac arrhyth-mias. Anesth Analg 1973;52:951–964.